TY - JOUR
TI - Ocrelizumab for multiple sclerosis
J2 - Aust Prescr
JF - Australian Prescriber
PY - 2018
ET - 2018/06/12
VL - 41
IS - 4
SP - 125
EP - 126
DO - 10.18773/austprescr.2018.028
LA - eng
UR - https://australianprescriber.tg.org.au/articles/ocrelizumab-for-multiple-sclerosis.html
KW - multiple sclerosis
KW - ocrelizumab
KW - Ocrevus
PB - Therapeutic Guidelines Ltd
SN - 1839-3942
ER -